Recently, the 2025VBEF Future Medical Top 100 list was officially released, and Polyseq Biotechnology won the "Future Medical Top 100 China Medical and Health Innovation Service List" and the "Best Biotechnology Product Award" for its outstanding innovation strength in the medical and health field.

Currently, China's healthcare industry is at a critical moment full of challenges and opportunities. Polyseq Biotechnology is driven by innovation in this industry context, constantly breaking through technological bottlenecks and injecting new vitality into the development of the industry. 

As a pioneer in nanopore sequencing technology, Polyseq Biotechnology will continue to adhere to the development philosophy of "innovation driven, product first", continuously deepen technological innovation, and strive to provide higher quality, efficient, and accurate products and solutions for the medical and health industry. 

In the future journey, Polyseq Biotechnology will continue to work with various partners, strengthen industrial cooperation, accelerate cross disciplinary technology integration, and jointly build a more complete medical innovation ecosystem.